JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3051
Metallus
MTUS
$867M
| $3.12M | ﹤0.01% |
170,081
+9,148
| +6% | +$171K |
2017 Q4
21 quarters
|
|
3052
Harmony Gold Mining
HMY
$10.8B
| $3.11M | ﹤0.01% |
758,460
+119,282
| +19% | +$425K |
2020 Q4
9 quarters
|
|
3053
BioNTech
BNTX
$24B
| $3.11M | ﹤0.01% |
24,955
-2,029
| -8% | -$279K |
2020 Q1
12 quarters
|
|
3054
PUT
iRhythm Holdings
IRTC
$3.53B
| $3.1M | ﹤0.01% |
+25,000
| New | +$2.71M |
2023 Q1
0 quarters
|
|
|
GDEN
3055
DELISTED
Golden Entertainment
GDEN
| $3.1M | ﹤0.01% |
71,242
+32,667
| +85% | +$1.32M |
2017 Q4
21 quarters
|
|
|
XRN
3056
Chiron Real Estate Inc
XRN
$454M
| $3.1M | ﹤0.01% |
68,066
-2,742
| -4% | -$138K |
2017 Q4
21 quarters
|
|
3057
PUT
Packaging Corp of America
PKG
$20.5B
| $3.1M | ﹤0.01% |
+22,300
| New | +$3.03M |
2023 Q1
0 quarters
|
|
3058
Tyra Biosciences
TYRA
$1.39B
| $3.09M | ﹤0.01% |
192,509
-6,698
| -3% | -$79.7K |
2021 Q4
5 quarters
|
|
3059
CALL
Vanguard Global ex-US Real Estate ETF
VNQI
$3.25B
| $3.09M | ﹤0.01% |
76,500
-157,600
| -67% | -$6.66M |
2022 Q1
4 quarters
|
|
3060
ZipRecruiter
ZIP
$303M
| $3.09M | ﹤0.01% |
193,960
+22,220
| +13% | +$401K |
2021 Q4
5 quarters
|
|
3061
CALL
CVS Health
CVS
$111B
| $3.08M | ﹤0.01% |
41,500
-97,500
| -70% | -$8.18M |
2021 Q2
7 quarters
|
|
3062
Frontdoor
FTDR
$5.43B
| $3.08M | ﹤0.01% |
110,636
+22,015
| +25% | +$582K |
2018 Q4
17 quarters
|
|
3063
CALL
Axalta
AXTA
$7.15B
| $3.08M | ﹤0.01% |
+101,700
| New | +$2.92M |
2023 Q1
0 quarters
|
|
3064
Vanguard Intermediate-Term Bond ETF
BIV
$28B
| $3.08M | ﹤0.01% |
40,110
-47,486
| -54% | -$3.6M |
2015 Q1
32 quarters
|
|
3065
CALL
Illumina
ILMN
$41.3B
| $3.07M | ﹤0.01% |
13,570
-3,392
| -20% | -$694K |
2022 Q2
3 quarters
|
|
|
VSTO
3066
DELISTED
Vista Outdoor Inc.
VSTO
| $3.07M | ﹤0.01% |
110,736
+21,344
| +24% | +$584K |
2015 Q1
32 quarters
|
|
|
APMI
3067
DELISTED
AxonPrime Infrastructure Acquisition Corporation Class A Common Stock
APMI
| $3.07M | ﹤0.01% |
295,000
| – | – |
2021 Q4
5 quarters
|
|
3068
IDT Corp
IDT
$1.99B
| $3.06M | ﹤0.01% |
89,765
-13,250
| -13% | -$408K |
2013 Q2
39 quarters
|
|
|
AVNS
3069
DELISTED
Avanos Medical
AVNS
| $3.06M | ﹤0.01% |
102,820
+9,481
| +10% | +$275K |
2014 Q4
33 quarters
|
|
3070
Ameresco
AMRC
$1.2B
| $3.06M | ﹤0.01% |
62,062
+4,394
| +8% | +$233K |
2017 Q4
21 quarters
|
|
3071
Green Dot
GDOT
$707M
| $3.05M | ﹤0.01% |
177,775
-109,859
| -38% | -$1.92M |
2013 Q2
39 quarters
|
|
3072
Collegium Pharmaceutical
COLL
$712M
| $3.05M | ﹤0.01% |
127,235
+4,061
| +3% | +$108K |
2017 Q3
22 quarters
|
|
|
TEN
3073
Tsakos Energy Navigation Ltd
TEN
$1.52B
| $3.05M | ﹤0.01% |
157,090
+87,175
| +125% | +$1.7M |
2020 Q4
9 quarters
|
|
3074
AtriCure
ATRC
$2.73B
| $3.05M | ﹤0.01% |
73,533
+12,652
| +21% | +$525K |
2017 Q3
22 quarters
|
|
3075
Coastal Financial
CCB
$623M
| $3.05M | ﹤0.01% |
84,607
-5,060
| -6% | -$218K |
2018 Q3
18 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.